checkAd

     438  0 Kommentare Real World Evidence (RWE) Solutions Likely to Grow at a CAGR of 14.1% and Significantly Drive Healthcare Decision-making, Predicts Roots Analysis - Seite 2

    • Jane Reed (Head of Life Science Strategy, Linguamatics)
    • Jonathan Moshinsky (Head of Market Strategy, uMotif)
    • Mark Cziraky (Vice President of Research, HealthCore)
    • Anonymous (Vice President, Big Pharmaceutical Company)

    The report covers detailed assessment of real world evidence related solutions of several companies, including (illustrative list, no selection criteria):

    • Aetion
    • Clinakos
    • Clinigen
    • Flatiron Health
    • HealthCore
    • IBM Watson Health
    • ICON
    • Ignite Data
    • Ingress
    • IQVIA
    • Linguamatics
    • MaxisIT
    • PARAXEL
    • PatientsLikeMe
    • pH Associates
    • RealHealthData
    • Saama Technologies
    • SAS Institute
    • SHYFT Analytics
    • uMotif
    • Vector Oncology
    • Wipro

    For additional details, please visit 

    https://www.rootsanalysis.com/reports/view_document/real-world-evidenc ...

    or email sales@rootsanalysis.com

    Contact:
    Gaurav Chaudhary
    +1-604-595-4954
    gaurav.chaudhary@rootsanalysis.com


    Seite 2 von 2




    PR Newswire (engl.)
    0 Follower
    Autor folgen
    Verfasst von PR Newswire (engl.)
    Real World Evidence (RWE) Solutions Likely to Grow at a CAGR of 14.1% and Significantly Drive Healthcare Decision-making, Predicts Roots Analysis - Seite 2 LONDON, October 18, 2018 /PRNewswire/ - Roots Analysis has announced the addition of "Real World Evidence: Market Landscape and Competitive Insights, 2018-2030" report to its list of offerings.      (Logo: …